Table 4 Number and proportion of RLS cases and controls with high c-aAb (IL-1α, IL-6, IL-10, IFN-α and GM-CSF -specific autoantibodies).
C-aAb | N | N cases | N controls | N cases with high c-aAba | N controls with high c-aAba | P-valueb |
|---|---|---|---|---|---|---|
IL-1α | 1471 | 73 | 1398 | 1 ≤ n ≤ 5 (1.4% ≤ n ≤ 6.8%)c | 13 (0.9%) | 0.168 |
IL-6 | 1477 | 75 | 1402 | 0 (0.0%) | 15 (1.1%) | 1 |
IL-10 | 1464 | 73 | 1391 | 0 (0.0%) | 14 (1.0%) | 1 |
IFN-α | 1476 | 75 | 1401 | 1 ≤ n ≤ 5 (1.3% ≤ n ≤ 6.7%)c | 12 (0.9%) | 0.037 |
GM-CSF | 1458 | 73 | 1385 | 0 (0.0%) | 15 (1.1%) | 1 |